Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 25;6(11):1869-1889.
doi: 10.1021/acscentsci.0c00599. Epub 2020 Sep 21.

Unconventional Macrocyclizations in Natural Product Synthesis

Affiliations
Review

Unconventional Macrocyclizations in Natural Product Synthesis

Iakovos Saridakis et al. ACS Cent Sci. .

Abstract

Over the past several decades, macrocyclic compounds have emerged as increasingly significant therapeutic candidates in drug discovery. Their pharmacological activity hinges on their rotationally restricted three-dimensional orientation, resulting in a unique conformational preorganization and a high enthalpic gain as a consequence of high-affinity macrocycle-protein binding interactions. Synthetic access to macrocyclic drug candidates is therefore crucial. From a synthetic point of view, the efficiency of macrocyclization events commonly suffers from entropic penalties as well as undesired intermolecular couplings (oligomerization). Although over the past several decades ring-closing metathesis, macrolactonization, or macrolactamization have become strategies of choice, the toolbox of organic synthesis provides a great number of versatile transformations beyond the aforementioned. This Outlook focuses on a selection of examples employing what we term unconventional macrocyclizations toward the synthesis of natural products or analogues.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. (a) Selected Examples of Common Macrocyclizations in Natural Product Synthesis and (b) Employment of Various Ring-Closing Techniques for the Construction of the Bis-Macrocyclic Natural Product Diazonamide A
Scheme 2
Scheme 2. Nicolaou’s “Stitching” Technique en Route to the First Total Synthesis of Rapamycin
Scheme 3
Scheme 3. Intramolecular Stille Couplings in the Syntheses of (a) Macrolactin A and (b) Sarain A
Scheme 4
Scheme 4. Heck Coupling toward the Synthesis of Etnangien by Menche
Scheme 5
Scheme 5. Stereoselective Macrocyclizations in the Syntheses of (a) Biselyngbyolide B and (b) Isoplagiochin D
Scheme 6
Scheme 6. Suzuki–Miyaura Couplings en Route to the Syntheses of (a) Phomactin A and (b) Isocomplestatin
Scheme 7
Scheme 7. Domino Suzuki–Miyaura/4π-Electrocyclic Ring Opening Developed by Maulide for the Syntheses of FR252921, FR252922, and FR256523
Scheme 8
Scheme 8. Tsuji–Trost Macrocyclizations in the Syntheses of (a) Humulene by Yamamoto, (b) Roseophilin by Fürstner, and (c) Macquarimicin A by Tadano
Scheme 9
Scheme 9. (a) Cascade Sonogashira Macrocyclization and Transannular Diels–Alder in the Synthesis of the Dynemicin A Core by Schreiber and (b) Hirama’s Development of a Kedarcidin Chromophore Fragment
Scheme 10
Scheme 10. (a) Palladium-Catalyzed Macrocyclization Developed by Trost en Route to Bryostatin 16 and (b) Boger’s Palladium-Mediated Transannular Larock Macrocyclization in the Synthesis of Streptide
Scheme 11
Scheme 11. (a) Wittig Macrocyclization by Nógrádi toward Garuganin III and (b) Double Wittig Olefination for the Syntheses of Trienomycins A and F by Smith
Scheme 12
Scheme 12. Ring-Closing Horner–Wadsworth–Emmons Olefination for in the Synthesis of Lasonolide A by Kang
Scheme 13
Scheme 13. HWE Macrocyclizations in the Syntheses of (a) Dactylolide by Keck and (b) Archazolid A by Menche
Scheme 14
Scheme 14. Aryl–Aryl Couplings Developed for the Syntheses of (a) Vancomycin Aglycon by Evans and (b) Arylomycin Core (72) by Baran
Scheme 15
Scheme 15. (a) Sorensen’s Diastereoselective Intramolecular Diels–Alder Reaction en Route to Abyssomicin C and (b) Corey’s Enantioselective Syntheses of Palominol and Dolabellatrienone
Scheme 16
Scheme 16. (a) Baran’s Diels–Alder/Retro-Diels–Alder Approach for the Synthesis of Haouamine A’s Bent Aromatic Ring and (b) Hetero-Diels–Alder Reaction Enabling Nicolaou’s Synthesis of Sporolide B
Scheme 17
Scheme 17. Macrolactonization/Diels–Alder Cyclization Sequence to Form the Core of a Dynemicin A Derivative
Scheme 18
Scheme 18. Evans’ Synthesis of Miyakolide via 1,3-Dipolar Cycloaddition
Scheme 19
Scheme 19. Hsung’s oxa-[3 + 3] Cycloaddition to Build the Phomactin A Core
Scheme 20
Scheme 20. Enantioselective, Rh-Catalyzed Synthesis of the Cylindrocyclophane Core by Davies
Scheme 21
Scheme 21. (a) Incomplete McMurry Reaction Affording Crassin-Intermediate 99, (b) SmI2-Induced Pinacol Coupling, as Applied by Corey, and (c) Nicolaou’s Heteropinacol-Macrocyclization en Route to Diazonamide A
Scheme 22
Scheme 22. Witkop-Cyclization Approaches to Diazonamide A by (a) Harran and (b) Nicolaou
Scheme 23
Scheme 23. Wurtz-Type Coupling Enabled Nógrádi’s Synthesis of Garugamblin-1
Scheme 24
Scheme 24. Temporary Addition of a Thiyl Radical Promotes a Giese Macrocyclization, Forming the Brefeldin A and C Core Structure
Scheme 25
Scheme 25. (a) Base- and (b) Lewis-Acid-Promoted Macroaldolization Reaction for the Syntheses of Epothilone A and Diazonamide A
Scheme 26
Scheme 26. Synthesis of an Advanced Intermediate of Calicheamicinone by Means of a Thiophenolate-Promoted Macroaldolization
Scheme 27
Scheme 27. Use of a Samarium-Mediated Reformatsky Reaction in the Synthesis of Cebulactam A1
Scheme 28
Scheme 28. Hosomi–Sakurai Reactions Led to the Desired Macrocyclizations in the Syntheses of (a) Bryostatin 1 by Wender and (b) the Cyanolide A Aglycon by Rychnovsky
Scheme 29
Scheme 29. (a) Romo’s Room-Temperature Barbier Reaction en Route to Gymnodimine and (b) Danishefsky’s Acetylide Addition for the Synthesis of Calicheamicinone
Scheme 30
Scheme 30. Nozaki–Hiyama–Kishi Approaches toward Phomactin A
Scheme 31
Scheme 31. Loh-Type Allylation Employed by Banwell in the Syntheses of Paecilomycin F and Cochliomycin C
Scheme 32
Scheme 32. Nickel-Catalyzed Alkyne-Aldehyde Reductive Coupling in the Synthesis of Amphidinolide T1 by Jamison
Scheme 33
Scheme 33. Hoveyda’s Synthesis of Chloropeptin I through a Chan–Evans–Lam Coupling
Scheme 34
Scheme 34. Ullmann-Type Etherification for the Macrocyclization of Hirsutellone B Developed by Uchiro
Scheme 35
Scheme 35. Biphasic Conditions Allow Glaser–Hay Coupling in Continuous Flow at High Concentrations for the Formal Synthesis of Ivorenolide A
Scheme 36
Scheme 36. Harrowven’s Corey–Seebach Reaction Enabled the Synthesis of Riccardin C

References

    1. Newman D. J.; Cragg G. M.. Bioactive Macrocycles from Nature. In Macrocycles in Drug Discovery; Royal Society of Chemistry, 2015; pp 1–36.
    1. Mallinson J.; Collins I. Macrocycles in New Drug Discovery. Future Med. Chem. 2012, 4, 1409–1438. 10.4155/fmc.12.93. - DOI - PubMed
    1. Marsault E.; Peterson M. L. Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery. J. Med. Chem. 2011, 54, 1961–2004. 10.1021/jm1012374. - DOI - PubMed
    1. Driggers E. M.; Hale S. P.; Lee J.; Terrett N. K. The Exploration of Macrocycles for Drug Discovery - an Underexploited Structural Class. Nat. Rev. Drug Discovery 2008, 7, 608–624. 10.1038/nrd2590. - DOI - PubMed
    1. Ermert P. Design, Properties and Recent Application of Macrocycles in Medicinal Chemistry. Chimia 2017, 71, 678–702. 10.2533/chimia.2017.678. - DOI - PubMed